Amanda Weir
Dados Biográficos
| ID | 6161135 |
|---|---|
| NOME | Amanda Weir |
| PRENOMES | Amanda |
| SOBRENOME | Weir |
| ASSINATURA | WEIR A |
| AFILIAÇÕES | Health Protection Scotland |
| ORCID | 0000-0003-4653-1440 |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 7 |
| TOTAL DE CITAÇÕES | 2 |
| TOTAL COMO AUTOR | 7 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2011 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2023 |
| ÍNDICE H | 1 |
Epidemiology of Sars-CoV-2 during the first three waves in Scotland
BACKGROUND: The early COVID-19 pandemic in Scotland-defined as the era before widespread access to vaccination and monoclonal antibody treatment-can be characterised into three distinct waves: March-July 2020, July 2020-April 2021 and May-August 2021. Each wave was met with various societal restrictions in an effort to reduce disease transmission and associated morbidity and mortality. Understanding the epidemiology of infections during these wav…
Increasing drug-related mortality rates over the last decade in Scotland are not just due to an ageing cohort
Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy
Seven years have elapsed since the Scottish Government launched its Hepatitis C Action Plan - a Plan to improve services to prevent transmission of infection, particularly among people who inject drugs (PWID), identify those infected and ensure those infected receive optimal treatment. The Plan was underpinned by industrial scale funding (around £100 million, in addition to the general NHS funding, will have been invested by 2015), and a web of a…
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs
Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study
Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testing
BACKGROUND: A key aim of the Hepatitis C Action Plan for Scotland was to reduce the undiagnosed population through awareness-raising activities, for general practitioners and those at risk, and the introduction of dried blood spot (DBS) sampling in community drug services to overcome barriers to testing. This study evaluates the impact of these activities on testing and diagnosis. METHODS: Data on hepatitis C virus (HCV) testing undertaken betwee…
Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users
Epidemiology of Sars-CoV-2 during the first three waves in Scotland
BACKGROUND: The early COVID-19 pandemic in Scotland-defined as the era before widespread access to vaccination and monoclonal antibody treatment-can be characterised into three distinct waves: March-July 2020, July 2020-April 2021 and May-August 2021. Each wave was met with various societal restrictions in an effort to reduce disease transmission and associated morbidity and mortality. Understanding the epidemiology of infections during these wav…
Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs
Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study
Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testing
BACKGROUND: A key aim of the Hepatitis C Action Plan for Scotland was to reduce the undiagnosed population through awareness-raising activities, for general practitioners and those at risk, and the introduction of dried blood spot (DBS) sampling in community drug services to overcome barriers to testing. This study evaluates the impact of these activities on testing and diagnosis. METHODS: Data on hepatitis C virus (HCV) testing undertaken betwee…
Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy
Seven years have elapsed since the Scottish Government launched its Hepatitis C Action Plan - a Plan to improve services to prevent transmission of infection, particularly among people who inject drugs (PWID), identify those infected and ensure those infected receive optimal treatment. The Plan was underpinned by industrial scale funding (around £100 million, in addition to the general NHS funding, will have been invested by 2015), and a web of a…
Increasing drug-related mortality rates over the last decade in Scotland are not just due to an ageing cohort
Epidemiology of Sars-CoV-2 during the first three waves in Scotland
BACKGROUND: The early COVID-19 pandemic in Scotland-defined as the era before widespread access to vaccination and monoclonal antibody treatment-can be characterised into three distinct waves: March-July 2020, July 2020-April 2021 and May-August 2021. Each wave was met with various societal restrictions in an effort to reduce disease transmission and associated morbidity and mortality. Understanding the epidemiology of infections during these wav…
Medicine (5 obras) · Environmental health (4 obras) · Hepatitis C virus research (4 obras) · HIV, Drug Use, Sexual Risk (3 obras) · Population (3 obras) · Virology (3 obras) · Action plan (2 obras) · Demography (2 obras) · Internal Medicine (2 obras) · Liver Disease Diagnosis and Treatment (2 obras)